AccrualNet: A New NCI Online Resource to Support Clinical Trial Patient Accrual
The National Cancer Institute announced the launch of a new online resource, AccrualNet, in response to needs expressed by clinical trials professionals and investigators. Despite dedicated clinical trial recruitment efforts, successful accrual remains a challenge - only 3-5% of potentially eligible cancer patients enroll in clinical trials. AccrualNet is designed for practicing professionals to support clinical trial accrual needs. The Web site is a repository for literature and other resources and serves as a 'community of practice' to encourage dialog and discussion. AccrualNet includes:
- Linkable access to existing tools and materials your colleagues are using
- A searchable list of published journal articles on clinical trial recruitment
- A space to ask questions and share experiences and strategies
- Training opportunities available to orient and educate new staff to successful recruitment strategies
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
